financetom
MA
financetom
/
Financials
/
MA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Mastercard IncorporatedMA
528.03USD
+4.75 (0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
484.64B
Revenue (ttm)
27.23B
Net Income (ttm)
12.32B
Shares Out
917.83M
EPS (ttm)
13.23
PE Ratio
39.92
Forward PE
33.72
Dividend
$2.64 (0.50%)
Ex-Dividend Date
Oct 9, 2024
Volume
7,284,940
Open
522.87
Previous Close
523.28
Day's Range
519.83 - 532.01
52-Week Range
416.53 - 537.13
Beta
1.10
Analysts
Strong Buy
Price Target
567.17 (+7.41%)
Earnings Date
Jan 29, 2025
Description >

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally.

It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services.

The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid programs services; and commercial credit, debit, and prepaid payment products and solutions.

It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services.

In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants.

Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus.

Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.

Latest News >
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
May 7, 2024
SAO PAULO, May 7 (Reuters) - Competing Brazilian meatpackers have joined forces to circumvent problems caused by heavy flooding in Rio Grande do Sul state, where torrential rains severely disrupted operations, a local meat lobby said on Tuesday. Jose Ribas, who presides over Sindicarne in the neighboring state of Santa Catarina, said local meatpackers were working in partnership to overcome...
Campari has taste for more M&A after Courvoisier deal, new CEO says
Campari has taste for more M&A after Courvoisier deal, new CEO says
May 7, 2024
MILAN, May 7 (Reuters) - Campari will seek further M&A opportunties after completing the buyout of French cognac house Courvoisier, the new head of the Italian drinks group said on Tuesday. The group completed the 1.22-billion euro ($1.3 billion)acquisition of Courvoisier last week, earlier than expected by analysts. It was the largest ever deal for Campari, whose brands include the...
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
May 7, 2024
12:28 PM EDT, 05/07/2024 (MT Newswires) -- Exxon Mobil ( XOM ) plans to set up a single North American research and technology hub at its Houston headquarters and close campuses in Clinton, New Jersey, and Sarnia in Ontario, Bloomberg reported Tuesday, citing a company spokeswoman. The majority of 700 workers affected by the closures are being offered roles in...
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
May 7, 2024
12:24 PM EDT, 05/07/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) and Agenus ( AGEN ) said Tuesday they have signed a royalty financing agreement to support the clinical development of Agenus' ( AGEN ) botensilimab and balstilimab, including a confirmatory phase 3 trial in metastatic, relapsed or refractory colorectal cancer. Under the terms of the agreement, Ligand will...
Copyright 2023-2024 - www.financetom.com All Rights Reserved